股份注销

Search documents
*ST金科:拟注销3706万股回购股份
Xin Lang Cai Jing· 2025-09-30 11:24
Core Viewpoint - The company plans to cancel 37.06 million shares of publicly held stock that were repurchased, due to the failure to implement an employee stock ownership plan or equity incentive plan within 36 months after the termination of the share buyback [1] Group 1 - The cancellation of shares has been approved by the board of directors and will be submitted for shareholder meeting approval [1] - Following the cancellation, the company's registered capital will decrease accordingly, but this will not negatively impact the company's operations, finances, research and development, debt fulfillment capability, or future development [1] - The cancellation will not lead to any changes in the company's control [1]
新点软件:拟3000万元—5000万元回购公司股份
Zheng Quan Shi Bao Wang· 2025-09-24 08:41
另外,公司拟将回购专用证券账户中的回购股份801.8万股的用途进行调整,由"用于股权激励或员工持 股计划"变更为"用于注销并相应减少注册资本",注销完成后有利于增加每股收益。 人民财讯9月24日电,新点软件(688232)9月24日公告,公司拟通过集中竞价交易的方式,以3000万元— 5000万元回购公司股份,回购价格不超过42元/股,回购的股份将用于股权激励或员工持股计划。 ...
广东东峰新材料集团股份有限公司关于股份回购实施结果暨股份变动的公告
Shang Hai Zheng Quan Bao· 2025-09-21 18:11
Group 1 - The company approved a share repurchase plan with a total fund of no less than RMB 50 million and no more than RMB 100 million, with a maximum repurchase price of RMB 3.93 per share [1] - The maximum repurchase price was later adjusted to RMB 6.28 per share to ensure the smooth implementation of the repurchase plan [2] - The company completed the share repurchase by acquiring a total of 13,089,904 shares, accounting for approximately 0.70% of the current total share capital, with a total payment of RMB 51,996,173.16 [3] Group 2 - The repurchased shares will be used for cancellation and reduction of the company's registered capital, with the cancellation process scheduled for September 22, 2025 [7] - The shareholding structure of the controlling shareholder will change, with the proportion of shares held by the new controlling shareholder increasing from 29.87% to 30.08% after the cancellation of the repurchased shares [9] - The company has complied with relevant laws and regulations during the share repurchase process, ensuring that the execution aligns with the disclosed repurchase plan [3][6]
北京初一女生HPV疫苗免费接种全面启动;赛诺菲创新药在华获批
2 1 Shi Ji Jing Ji Bao Dao· 2025-09-08 00:42
Group 1: Pharmaceutical Companies and Products - 63 pharmaceutical companies have been exposed for serious credit violations, with 63 companies rated as "particularly serious" or "serious" by the National Medical Insurance Administration [1] - Junshi Biosciences announced positive results from a Phase III clinical trial of JS005 for moderate to severe plaque psoriasis, planning to submit a marketing application soon [1] - Sanofi's teplizumab injection has been approved in China for delaying the progression of type 1 diabetes in patients aged 8 and above [2] Group 2: Corporate Actions - Yingke Medical adjusted its share repurchase price limit from RMB 26.51 to RMB 41.88 per share, effective from September 8, 2025, with a total repurchase fund of RMB 80 million to 120 million [3] - Qidi Pharmaceutical plans to change its name to "Guhan Health Industry Group Co., Ltd." and will revise its articles of association accordingly [4] - Jiuan Medical intends to cancel 9.77 million shares, which is 2.06% of its total share capital, as part of a strategy to enhance shareholder returns [5] Group 3: Market Movements and Regulations - Xiangrikui is planning to acquire controlling stakes in Xi Pu Materials and 40% of Beid Pharmaceutical, leading to a temporary suspension of its stock [6] - Beijing has launched a free HPV vaccination program for new first-year junior high school girls, aiming to increase vaccination rates [7][8] - Two studies on iza-bren (EGFR×HER3 dual antibody ADC) have been selected for the official news release program at the 2025 WCLC, highlighting its clinical significance [9] Group 4: Shareholder Actions - Chengda Pharmaceutical announced that a shareholder plans to reduce their stake by up to 7.27% within three months [10] - Kangchen Pharmaceutical's controlling shareholder plans to reduce their stake by up to 3% between September 29 and December 28, 2025, due to personal funding needs [11]
九安医疗:拟注销977.19万股股份
Xin Lang Cai Jing· 2025-09-05 09:16
Core Viewpoint - The company plans to change the purpose of repurchasing 9,106,900 shares, which were bought back on August 29, 2023, to "cancel and reduce the company's registered capital" [1] Group 1: Share Repurchase and Capital Reduction - The number of shares to be canceled is 9,771,900, accounting for 2.06% of the company's current total share capital [1] - After the cancellation, the total share capital will decrease from 475 million shares to 465 million shares [1] - This move aims to actively maintain the company's market value and enhance shareholder returns [1] Group 2: Financial Impact - The change in the purpose of the repurchased shares and the cancellation will not have a significant impact on the company's financial condition, operating results, or future development [1] - There will be no change in the controlling shareholder or actual controller of the company as a result of this action [1]
中国平安(02318)拟注销1.03亿股A股已回购股份
智通财经网· 2025-09-02 12:06
Group 1 - The company announced the cancellation of 103 million A-shares repurchased under the 2021 A-share repurchase plan, which will reduce its registered capital and amend the Articles of Association [1] - The company has completed the creditor notification process as required by laws and regulations, and no creditors have requested debt repayment or provided guarantees during the claim period [1] - The company has received approval from the National Financial Supervision Administration for the change in registered capital and submitted the relevant application to the Shanghai Stock Exchange, with the cancellation expected to be completed by September 3, 2025 [1] Group 2 - Following the cancellation, the total share capital will decrease from 18.21 billion shares to 18.11 billion shares, consisting of 10.66 billion A-shares and 7.448 billion H-shares [1]
天齐锂业: 关于变更部分回购股份用途并注销的公告
Zheng Quan Zhi Xing· 2025-08-29 14:18
Core Viewpoint - Tianqi Lithium Industries, Inc. has decided to change the purpose of part of its repurchased shares from an employee stock incentive plan to cancellation and reduction of registered capital, aiming to optimize its capital structure and protect shareholder interests [1][5][6] Group 1: Share Repurchase Implementation - The company approved a share repurchase plan using its own funds, with a maximum repurchase price of RMB 150 per share and a total repurchase amount between RMB 136 million and RMB 200 million [1][2] - The repurchase was completed at an average price of RMB 112.33 per share, totaling approximately RMB 199.985 million [1][2] Group 2: Change of Purpose for Repurchased Shares - The company plans to change the use of 26,600 shares from the original purpose of an A-share incentive plan to cancellation and reduction of registered capital [3][5] - This decision aligns with the regulations that require unused repurchased shares to be canceled if not utilized within three years [3][5] Group 3: Impact of the Change - The change in the purpose of repurchased shares is expected to have no significant impact on the company's financials, operations, or control structure, and the share distribution will still meet listing requirements [5][6] - The supervisory board has reviewed and agreed that the change complies with relevant regulations and does not harm the interests of the company or its shareholders [5][6] Group 4: Next Steps - The change in the purpose of repurchased shares requires approval from the shareholders' meeting and subsequent procedures with the Shenzhen Stock Exchange and relevant authorities for share cancellation [6]
浙江恒威:拟注销109.18万股股份
Xin Lang Cai Jing· 2025-08-28 12:25
Core Viewpoint - The company has decided to change the purpose of its share repurchase from employee stock ownership plans to cancellation and reduction of registered capital [1] Group 1 - The company will repurchase 1.0918 million shares, changing the purpose from potential employee stock ownership or equity incentives to cancellation [1] - After the cancellation, the total share capital will decrease from 101 million shares to 100 million shares [1] - The registered capital will be reduced from RMB 101 million to RMB 100 million following the cancellation [1] - This proposal will be submitted for approval at the company's first extraordinary general meeting in 2025 [1]
联泰环保拟注销788.54万股回购股份 注册资本预计减少788.54万元
Xin Lang Cai Jing· 2025-08-27 11:32
Core Viewpoint - The company announced the cancellation of repurchased shares and a corresponding reduction in registered capital to enhance investor confidence and comply with regulatory requirements [1][2]. Group 1: Share Repurchase and Capital Reduction - On June 23, 2025, the company held its 2024 annual general meeting, where it approved the proposal to cancel repurchased shares and reduce registered capital [1]. - The company plans to cancel a total of 7,885,396 shares from its repurchase account, which will lead to a reduction in registered capital from 584,490,586 yuan to 576,605,190 yuan [2]. Group 2: Creditor Notification and Claims - Following the capital reduction, the company is required to notify creditors, who have 30 days from receiving the notice to claim their debts or provide guarantees [2]. - Creditors who do not receive notification have 45 days from the announcement date to assert their claims, and the company will continue to fulfill its obligations as per the original debt documents [2]. Group 3: Claim Submission Process - The claim submission period is from August 28, 2025, to October 11, 2025, during working hours [3]. - Creditors must provide specific documentation depending on whether they are legal entities or individuals when submitting their claims [3].
华联控股股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-26 21:19
Core Points - The company has not distributed cash dividends or bonus shares during the reporting period [3] - The company has implemented a share repurchase plan, buying back 8,414,980 shares, which is 0.57% of the total share capital, with a total transaction amount of approximately RMB 30 million [5] - The company completed the cancellation of 80,115,300 shares from the previous year's repurchase, reducing the total share capital from 1,483,934,025 shares to 1,403,818,725 shares [6] Company Overview - The company has not experienced any changes in its controlling shareholder or actual controller during the reporting period [5] - The company is involved in a city renewal project called "Hualian A District," covering an area of 84,818 square meters, with a planned residential area of 255,872 square meters, including 141,280 square meters of affordable housing [4] Board Meeting - The company's board of directors held its second meeting of the twelfth session on August 25, 2025, with all seven directors present [8] - The board approved the 2025 semi-annual report and several governance-related proposals, including the establishment of a management system for departing directors and senior management [12][13][15]